Brazil to buy AIDS drugs from India
The Brazil government has decided to purchase the cheaper drugs from an Indian lab.
The measure was adopted on Friday after long and unfruitful governmental negotiations with the US Merck Sharp and Dohme lab, producer of Efavirenz, a substitute for AZT.
The US lab sold Brazil that medicine valued at $1.50 and the country decided to purchase it from India, where a lab sells it for $0.44.
According to reports, the Merck lab supplied Efavirenz to Brazil at 136 per cent than what the same lab distributes to Thailand.
The decision was explained by Health Minister Jose Gomes Temporao, as part of a policy to provide the medicine to 75,000 AIDS patients in Brazil.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.